2020 Virtual ESMO Review


 

2020 ESMO Update on MBC: Is There OS Benefit to Alpelisib + Fulvestrant in PI3KCA-Mutated HR+ MBC? Does Sacituzumab Govitecan Improve PFS & OS Over Standard Chemotherapy in mTNBC?

121 views
November 4, 2020
Comments 0
Login to view comments. Click here to Login